NPA101.3
NPA101.3 is a second-generation small molecule inhibitor targeting both RET and VEGFR2 kinases. It is a promising preclinical candidate for the treatment of RET-driven cancers, such as thyroid and non-small cell lung cancer, with demonstrated activity in relevant in vitro and in vivo models.
Product Specifications
CAS Number
1839155-15-5
Smiles
C (C (NC=1C=C (C (C) (C) C) ON1) =O) C2=CC=C (N3C=4C (=CC (=CC4) C5=CC=C (S (C) (=O) =O) C=C5) N=C3) C=C2
Molecular Formula
C29H28N4O4S
Molecular Weight
528.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
22658111 3x 1.0 µg
GRIA3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details P1374-100 100 µg
Human CellExp™ CSF1R/CD115, Fc Tag, Human Recombinant,
Sign In for Pricing
View Details 44509126 3x 1.0µg DNA
SNAPC5 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details MBS7115213-01 0.02 mg (E-Coli)
Recombinant Human Glutathione S-Transferase P (GSTP1)
Sign In for Pricing
View Details MBS7115213-02 0.1 mg (E-Coli)
Recombinant Human Glutathione S-Transferase P (GSTP1)
Sign In for Pricing
View Details MBS7115213-03 1 mg (E-Coli)
Recombinant Human Glutathione S-Transferase P (GSTP1)
Sign In for Pricing
View Details